NCT03431818 is a clinical trial of Nasal cannula flow rate in Oxygen Therapy, sponsored by University of Miami.

Who is sponsoring NCT03431818?

NCT03431818 is sponsored by University of Miami.

What drugs are being tested in NCT03431818?

Interventions in NCT03431818: Nasal cannula flow rate.

What condition does NCT03431818 study?

NCT03431818 studies Oxygen Therapy.

Is NCT03431818 still recruiting?

NCT03431818 is currently completed. Last updated 20 March 2025.

Last reviewed 2025-03-20 · How we verify

NCT03431818

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effective Fraction of Inspired Oxygen With Nasal Cannula in Premature Infants

Completed Last updated 20 March 2025

What this trial tests

trial testing Nasal cannula flow rate in Oxygen Therapy in 35 participants. Completed in 7 September 2023.

Timeline

4 April 2018

Primary endpoint
1 January 2023

7 September 2023

Quick facts

Lead sponsor	University of Miami
Status	Completed
Study type	OBSERVATIONAL
Enrollment	35
Start date	4 April 2018
Primary completion	1 January 2023
Estimated completion	7 September 2023
Sites	1 location across United States

Drugs / interventions tested

Nasal cannula flow rate

Conditions studied

Oxygen Therapy — all drugs for Oxygen Therapy →

Sponsor

University of Miami

Who can join

Eligibility, any sex, with Oxygen Therapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to determine the multifactorial relationship between the effective fraction of inspired oxygen (Effective-FiO2) and the FiO2 in the gas delivered by the nasal cannula (NC-FiO2), NC flow rate, spontaneous minute ventilation and other patient characteristics in premature infants who receive supplemental oxygen via nasal cannula (NC).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Oxygen Therapy

Currently open trials in the same condition.

NCT06816706 — Comparison of Physiological Effects of Two High-Flow Tracheal Oxygen Versus T-Piece During Spontaneous Breathing Trials · NA · recruiting

Other University of Miami trials

Trials by the same sponsor.

NCT06003712 — Exploring the Effect of Mindfulness on Quality of Life (QoL) in Spinal Cord Injury (SCI) · NA · not yet recruiting
NCT06077071 — MRIdian "RADAR" Trial · NA · not yet recruiting
NCT07472413 — Alternate Pre-med in Anti-Cluster of Differentiation 20 (CD20) Pilot Project · Phase 3 · not yet recruiting
NCT07322289 — Antibiotic-coated Braided Suture Study · NA · not yet recruiting
NCT07469592 — eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03431818 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Miami
Last refreshed: 20 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03431818.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing